• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析脓毒症患者的炎症介质谱表明,非幸存者的细胞外组蛋白水平显著升高。

Analysis of Inflammatory Mediator Profiles in Sepsis Patients Reveals That Extracellular Histones Are Strongly Elevated in Nonsurvivors.

机构信息

Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis, Danube University Krems, Krems, Austria.

Department for Biomedical Research, Center for Biomedical Technology, Danube University Krems, Krems, Austria.

出版信息

Mediators Inflamm. 2021 Mar 17;2021:8395048. doi: 10.1155/2021/8395048. eCollection 2021.

DOI:10.1155/2021/8395048
PMID:33790693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7994100/
Abstract

The timely recognition of sepsis and the prediction of its clinical course are challenging due to the complex molecular mechanisms leading to organ failure and to the heterogeneity of sepsis patients. Treatment strategies relying on a "one-fits-all" approach have failed to reduce mortality, suggesting that therapeutic targets differ between patient subgroups and highlighting the need for accurate analysis of the molecular cascades to assess the highly variable host response. Here, we characterized a panel of 44 inflammatory mediators, including cytokines, chemokines, damage-associated molecular patterns, and coagulation-related factors, as well as markers of endothelial activation in 30 patients suffering from renal failure in the course of sepsis. All patients received continuous veno-venous hemodialysis with either high cut-off filters or with standard filters, and mediators were quantified for all patients at the initiation of dialysis and after 24 h and 48 h. Mediator concentrations in individual patients ranged widely, demonstrating the heterogeneity of sepsis patients. None of the mediators correlated with SAPS III or TISS scores. The overall in-hospital mortality of the study population was 56.7% (57.1% 56.3% for high cut-off standard filter). The two filter groups differed regarding most of the mediator levels at baseline, prohibiting conclusions regarding the effect of standard filters high cut-off filters on mediator depletion. The elevation and correlation of damage-associated molecular patterns and markers of endothelial activation gave evidence of severe tissue damage. In particular, extracellular histones were strongly increased and were almost 30-fold higher in nonsurvivors as compared to survivors, indicating their diagnostic and prognostic potential.

摘要

由于导致器官衰竭的复杂分子机制以及脓毒症患者的异质性,及时识别脓毒症及其临床病程预测具有挑战性。依赖于“一刀切”方法的治疗策略未能降低死亡率,这表明治疗靶点在患者亚组之间存在差异,突出了需要准确分析分子级联反应,以评估宿主反应的高度可变性。在这里,我们在 30 名脓毒症合并肾衰竭患者中,鉴定了包括细胞因子、趋化因子、损伤相关分子模式和凝血相关因子以及内皮激活标志物在内的 44 种炎症介质的特征。所有患者均接受持续静脉-静脉血液透析,使用高截留过滤器或标准过滤器,在开始透析时以及透析 24 和 48 小时后对所有患者定量测定介质。个体患者的介质浓度差异很大,表明脓毒症患者存在异质性。没有一种介质与 SAPS III 或 TISS 评分相关。研究人群的总住院死亡率为 56.7%(高截留 标准过滤器为 57.1% 56.3%)。两组患者在基线时的大多数介质水平存在差异,因此无法得出关于标准过滤器 高截留过滤器对介质耗竭影响的结论。损伤相关分子模式和内皮激活标志物的升高和相关性表明存在严重的组织损伤。特别是细胞外组蛋白明显升高,非幸存者几乎是幸存者的 30 倍,表明其具有诊断和预后潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6612/7994100/6f06cdd4bd86/MI2021-8395048.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6612/7994100/3d62b3fe7390/MI2021-8395048.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6612/7994100/cc6b32429863/MI2021-8395048.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6612/7994100/2fd4ec470ca8/MI2021-8395048.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6612/7994100/6f06cdd4bd86/MI2021-8395048.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6612/7994100/3d62b3fe7390/MI2021-8395048.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6612/7994100/cc6b32429863/MI2021-8395048.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6612/7994100/2fd4ec470ca8/MI2021-8395048.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6612/7994100/6f06cdd4bd86/MI2021-8395048.004.jpg

相似文献

1
Analysis of Inflammatory Mediator Profiles in Sepsis Patients Reveals That Extracellular Histones Are Strongly Elevated in Nonsurvivors.分析脓毒症患者的炎症介质谱表明,非幸存者的细胞外组蛋白水平显著升高。
Mediators Inflamm. 2021 Mar 17;2021:8395048. doi: 10.1155/2021/8395048. eCollection 2021.
2
Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets.脓毒症循环组蛋白:潜在的预后预测因子和治疗靶点。
Front Immunol. 2021 Mar 24;12:650184. doi: 10.3389/fimmu.2021.650184. eCollection 2021.
3
Effects of Changes in the Levels of Damage-Associated Molecular Patterns Following Continuous Veno-Venous Hemofiltration Therapy on Outcomes in Acute Kidney Injury Patients With Sepsis.连续性静脉-静脉血液滤过治疗后损伤相关分子模式水平变化对脓毒症急性肾损伤患者结局的影响。
Front Immunol. 2019 Jan 7;9:3052. doi: 10.3389/fimmu.2018.03052. eCollection 2018.
4
[Prediction value of plasma histone in prognosis of sepsis patients].[血浆组蛋白对脓毒症患者预后的预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jun;31(6):674-679. doi: 10.3760/cma.j.issn.2095-4352.2019.06.003.
5
Clearance of Selected Plasma Cytokines with Continuous Veno-Venous Hemodialysis Using Ultraflux EMiC2 versus Ultraflux AV1000S.使用 Ultraflux EMiC2 与 Ultraflux AV1000S 行连续静-静脉血液透析清除选定的血浆细胞因子。
Blood Purif. 2017;44(4):260-266. doi: 10.1159/000478965. Epub 2017 Oct 7.
6
Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation.血浆组蛋白在人类脓毒症中的作用及其对细胞损伤和炎症的影响。
Crit Care. 2014 Sep 24;18(5):543. doi: 10.1186/s13054-014-0543-8.
7
Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis.严重脓毒症患者血乳酸浓度与胃黏膜内pH值的联合测定
Crit Care Med. 1995 Jul;23(7):1184-93. doi: 10.1097/00003246-199507000-00006.
8
Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients.持续静脉-静脉血液滤过联合透析可清除脓毒症患者循环中的细胞因子。
Crit Care Med. 1993 Apr;21(4):522-6. doi: 10.1097/00003246-199304000-00011.
9
Circulating Histones Are Major Mediators of Multiple Organ Dysfunction Syndrome in Acute Critical Illnesses.循环组蛋白是急性危重病中多器官功能障碍综合征的主要介导物。
Crit Care Med. 2019 Aug;47(8):e677-e684. doi: 10.1097/CCM.0000000000003839.
10
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.

引用本文的文献

1
Point of care sepsis diagnosis: Exploring microfluidic techniques for sample preparation, biomarker isolation, and detection.床旁脓毒症诊断:探索用于样品制备、生物标志物分离和检测的微流控技术。
Biomicrofluidics. 2025 Jul 1;19(4):041502. doi: 10.1063/5.0248096. eCollection 2025 Jul.
2
A Fully Integrated Microfluidic Device with Immobilized Dyes for Simultaneous Detection of Cell-Free DNA and Histones from Plasma Using Dehydrated Agarose Gates.一种具有固定染料的全集成微流控装置,用于使用脱水琼脂糖门控同时检测血浆中的游离DNA和组蛋白。
Gels. 2024 Mar 8;10(3):186. doi: 10.3390/gels10030186.
3
Neutrophil extracellular traps in urinary tract infection.

本文引用的文献

1
Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.白细胞介素-6、C 反应蛋白和降钙素原对 COVID-19 患者的预后价值。
J Clin Virol. 2020 Jun;127:104370. doi: 10.1016/j.jcv.2020.104370. Epub 2020 Apr 14.
2
Staging and Personalized Intervention for Infection and Sepsis.感染与脓毒症的分期与个体化干预
Surg Infect (Larchmt). 2020 Nov;21(9):732-744. doi: 10.1089/sur.2019.363. Epub 2020 Apr 2.
3
The ratio of plasma angiopoietin-2 to angiopoietin-1 as a prognostic biomarker in patients with sepsis.
尿路感染中的中性粒细胞胞外诱捕网
Front Pediatr. 2023 Mar 20;11:1154139. doi: 10.3389/fped.2023.1154139. eCollection 2023.
4
Activated Platelets and Platelet-Derived Extracellular Vesicles Mediate COVID-19-Associated Immunothrombosis.活化血小板和血小板衍生的细胞外囊泡介导新冠病毒相关免疫性血栓形成。
Front Cell Dev Biol. 2022 Jul 6;10:914891. doi: 10.3389/fcell.2022.914891. eCollection 2022.
5
Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones.肝素化吸附剂消除免疫血栓形成的中心效应物,包括血小板因子 4、高迁移率族蛋白 B1 蛋白和组蛋白。
Int J Mol Sci. 2022 Feb 5;23(3):1823. doi: 10.3390/ijms23031823.
脓毒症患者血浆血管生成素-2 与血管生成素-1 比值作为预后生物标志物。
Cytokine. 2020 May;129:155029. doi: 10.1016/j.cyto.2020.155029. Epub 2020 Feb 12.
4
Endocan - a potential diagnostic marker for early onset sepsis in neonates.内皮糖蛋白——新生儿早发型败血症的一种潜在诊断标志物。
J Infect Dev Ctries. 2019 Apr 30;13(4):311-317. doi: 10.3855/jidc.11202.
5
DAMPs and NETs in Sepsis.脓毒症中的 DAMPs 和 NETs。
Front Immunol. 2019 Oct 30;10:2536. doi: 10.3389/fimmu.2019.02536. eCollection 2019.
6
Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion Criteria: A Post Hoc Analysis of the ADRENAL Trial.氢化可的松与安慰剂在符合 Sepsis-3 诊断标准和 APROCCHSS 研究纳入标准的脓毒性休克患者中的比较:ADRENAL 试验的事后分析。
Anesthesiology. 2019 Dec;131(6):1292-1300. doi: 10.1097/ALN.0000000000002955.
7
Heterogeneity in sepsis: new biological evidence with clinical applications.脓毒症的异质性:具有临床应用的新生物学证据。
Crit Care. 2019 Mar 9;23(1):80. doi: 10.1186/s13054-019-2372-2.
8
Circulating histone H3 levels in septic patients are associated with coagulopathy, multiple organ failure, and death: a single-center observational study.脓毒症患者循环中组蛋白H3水平与凝血病、多器官功能衰竭及死亡相关:一项单中心观察性研究
Thromb J. 2019 Jan 14;17:1. doi: 10.1186/s12959-018-0190-4. eCollection 2019.
9
Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls.体外技术治疗脓毒症危重症患者:承诺与陷阱(超出常规血液净化治疗范围)。
Crit Care. 2018 Oct 25;22(1):262. doi: 10.1186/s13054-018-2181-z.
10
The Central Role of the Inflammatory Response in Understanding the Heterogeneity of Sepsis-3.炎症反应在理解 Sepsis-3 异质性中的核心作用。
Biomed Res Int. 2018 Jun 7;2018:5086516. doi: 10.1155/2018/5086516. eCollection 2018.